CEP Magazine - November 2022. Two sides of the coin: Proactive versus reactive compliance management
There is virtually no activity conducted by pharmaceutical and biotechnology companies that is not monitored for compliance. Requirements such as good laboratory practices, good clinical practices, ...
Your colleagues are used to it, more or less – the sight of you rushing through the office door, phone to your ear, just moments away from opening file cabinet drawers and thumping file folders on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results